LDC3140
Product Specifications
UNSPSC Description
LDC3140 is a selective CDK7 inhibitor (IC50CDK7, LDC3140 affects the regulation of the cell cycle, leading to cell cycle arrest and thus inhibiting the proliferation of tumor cells. LDC3140 can be used in the research of cancer treatment[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ldc3140.html
Smiles
CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC4=CC=CC=C4N(C)C)N2N=C1
Molecular Weight
423.55
References & Citations
[1]H Liang, et al. Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy. Expert Opinion on Investigational Drugs 30.1 (2021): 61-76.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-18969/LDC3140-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-18969/
Clinical Information
No Development Reported
CAS Number
1453833-30-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![NCF4 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI12H10]](https://cdn.genprice.uk/products/937/6868c3f3994c49e6dc402760/imageurl/ta809153bm.webp)
TA809153BM 100 µL
NCF4 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI12H10]
Ask
View Details